C
Cezary Szczylik
Researcher at Medical University of Warsaw
Publications - 291
Citations - 30393
Cezary Szczylik is an academic researcher from Medical University of Warsaw. The author has contributed to research in topics: Renal cell carcinoma & Cancer. The author has an hindex of 49, co-authored 274 publications receiving 27380 citations. Previous affiliations of Cezary Szczylik include Military Medical Academy & Cora.
Papers
More filters
Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases
Jakub Żołnierek,Paweł Nurzyński,Przemysław Langiewicz,Sylwia Oborska,Anna Waśko-Grabowska,Ewa Kusztal,Beata Obrocka,Cezary Szczylik +7 more
TL;DR: Overall, sunitinib appeared slightly more effective than sorafenib or IFN-alfa at extending mean time to progression of pre-existing bone lesions and prolonged time to occurrence of new bone lesions.
Journal ArticleDOI
Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line
MSc. Mohammed Imran Khan,Konrad J. Dębski,Michal Dabrowski,Anna M. Czarnecka,Cezary Szczylik +4 more
TL;DR: The data suggest that there are multiple deregulated pathways associated with metastatic clear cell renal cell carcinoma (mccRCC), including integrin-linked kinase (ILK) signaling, leukocyte extravasation signaling, IGF-I signaling, CXCR4 signaling, and phosphoinositol 3-kinase/AKT/mammalian target of rapamycin signaling.
Journal ArticleDOI
A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options
TL;DR: It’s shown that direct hits to the immune system are more likely to be associated with dementia than other types of injuries, including gunshot wounds.
Journal ArticleDOI
KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC)
Frede Donskov,David F. McDermott,J.-L. Lee,Cezary Szczylik,Jahangeer Malik,Boris Alekseev,J.M.G. Larkin,Vsevolod Matveev,R. Airatovich Gafanov,Piotr Tomczak,Scott S. Tykodi,Poul F. Geertsen,Paweł Wiechno,S.J. Shin,Frédéric Pouliot,T. Alonso Gordoa,R. Kloss Silverman,Rodolfo F. Perini,Charles Schloss,Michael B. Atkins +19 more
Journal ArticleDOI
Genomic analysis as the first step toward personalized treatment in renal cell carcinoma
TL;DR: Current state-of-the-art knowledge on the potential biomarkers of RCC subtypes; significant obstacles encountered in the translational research on RCC; and recent molecular findings that may have a crucial impact on future therapeutic approaches are discussed.